C09CA07 · Cardiovascular system
Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)
Indications
Hypertension Treatment of essential hypertension in adults. Cardiovascular prevention Reduction of cardiovascular morbidity in patients with: manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or; type-2 diabetes mellitus with documented target-organ damage.
Composition
- Active substance
- telmisartan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)
- Active substance
- telmisartan
- ATC code
- C09CA07
- Therapeutic area
- Hypertension
- Marketing authorisation holder